Stamford, CT -- (SBWIRE) -- 10/21/2013 -- OTC Stock Picks is engaged in providing the most up to date and useful information on the Best Penny Stocks that are poised to breakout. Our newsletter alerts the market with picks that Wall Street stock traders have ignored or haven’t found out about yet. Here are some of the most awesome penny stocks we came up with that the ‘underground penny stock experts’ are always bragging about in their penny stock newsletters. Have a look on today’s market movers: athenahealth, Inc(NASDAQ:ATHN), Immunomedics, Inc.(NASDAQ:IMMU), Anacor Pharmaceuticals Inc(NASDAQ:ANAC), Vanda Pharmaceuticals Inc.(NASDAQ:VNDA)
athenahealth, Inc(NASDAQ:ATHN) stock is at $130.83, up +24.05 percent from its previous close of $105.46. The stock opened the session at $117.46 and touched its highest price point at $132.48. athenahealth stock’s lowest price point for the session stood at $117.28. Stocks graphical chart shows a bullish trend during its last one month’s trading session. It remained positive 18.65% during the previous three months trade. Its total trading volume is 3.35 million shares for the day, in comparison to its average trading volume of 415,447.00 shares. athenahealth, Inc., a business services company, provides ongoing billing, clinical-related, and other related services to medical group practices primarily in the United States.
For How Long ATHN’s Gloss will Attract Investors ? Find out via this report
Immunomedics, Inc.(NASDAQ:IMMU) stock is at $4.47, down -11.56 percent from its previous close of $5.06. Its today’s volume is 3.12 million shares, in comparison to its average trading volume of 1.20 million shares. The stock opened the session at $5.13 and touched its highest price point at $5.19. Immunomedics’s lowest price point for the session stood at $4.40 and its 52 week price range stood at $2.11 - $7.35. The company has a total of 82.94 million outstanding shares and its total market capitalization is $371.14 million. Its beta value stands at 1.68 times and earnings per share was $-0.16. Immunomedics, Inc., a biopharmaceutical company, focuses on the development of monoclonal antibody-based products for the targeted treatment of cancer, autoimmune, and other serious diseases.
Has IMMU Found The Bottom And Ready To Gain Momentum? Find Out Here
Anacor Pharmaceuticals Inc(NASDAQ:ANAC) opened the session at $13.30 and remained in the $12.95 to $14.10 price range during the session. The stock is +28.41 percent higher at $13.83. Volume closed the day at 2.71 million shares, its average volume being 349,579.00 shares. The company has a total of 40.56 million outstanding shares and its total market capitalization is $560.92 million. Its beta value stands at 1.51 times and earnings per share was $-1.60. ANC was a gainer in the 5 days activity and jumped about 25.48%. The one month performance of the stock was positive and it scored more than 35.06%. Anacor Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel small-molecule therapeutics derived from its boron chemistry platform.
Will ANAC Continue To Move Higher? Find Out Here
Vanda Pharmaceuticals Inc.(NASDAQ:VNDA) traded in the range of $7.67 and $9.58 in its previous trading session. The stock recorded the volume of 2.33 million shares, in comparison to its average daily trading volume of 641,205.00 shares. Company’s year to date performance remained optimistic with the rise of 119.33%. If we look at the last 6 months of trade, that is in the bullish zone with an increase of 68.75%. The stock opened at $9.52 and its closing price for the day was $7.83, down -17.58 percent from its previous close of $9.50. Vanda Pharmaceuticals, Inc., a biopharmaceutical company, offers development and commercialization of products for the treatment of central nervous system disorders.
Will VNDA Get Buyers Even After The Recent Rally? Find Out Here
About OTC Stock Picks
The team is among the US market leaders in connecting stocks to investors. With over two decades of market experience, the team prides itself on having the ‘pulse’ of the stock market. The company tracks over 100 different stocks with the goal of bringing investor attention to stock trading opportunities. The team is exceptional at predicting momentum-changes in stocks via technical analysis and fundamentals, and quickly relaying this information through its penny stock newsletter. The company offers investors Free Level II service and Free Real Time Stock Charts on its company website.
OTC Stock Picks is not a registered securities adviser. Investors should always conduct their own additional due diligence with any potential investment or highlighted company. The company provides updates on selected stocks via press releases, newsletters, and company website, but this should not be construed as a recommendation to buy or sell.
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)